Replies to post #141558 on NanoViricides Inc. (NNVC)

[arvitar]

Awesome! Maybe suggest to Anil that he address this in the update:

"We do not have a license from TheraCour for the manufacture, marketing and sale of a shingles drug, our lead drug candidate"
https://www.sec.gov/Archives/edgar/data/1379006/000114420419041547/tv525970_10k.htm p.57

Prospective investors aren't going to be interested in a company that doesn't have the rights needed to execute their business plan. The above shows they don't have those rights.

Since Diwan is the CEO of both Nanoviricides and Theracour, it makes things look a little suspicious if it is not addressed.

Like, why won't he license those rights from one company to the other, after two years of saying he would, when he controls both companies?